Biondo Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-55,605
Closed -$1.32M 87
2018
Q4
$1.32M Sell
55,605
-53,595
-49% -$1.46M 0.4% 43
2018
Q3
$4.24M Buy
109,200
+1,795
+2% +$64.7K 1.01% 32
2018
Q2
$3.6M Buy
107,405
+9,210
+9% +$328K 0.91% 38
2018
Q1
$3.56M Sell
98,195
-18,255
-16% -$632K 0.93% 38
2017
Q4
$3.71M Buy
+116,450
New +$3.99M 0.94% 38

Other funds holding LMAT

Biondo Investment Advisors's LMAT Position: Q1 2019 in Review

Biondo Investment Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2019, closing a stake of 55,605 shares — an estimated $1.32M sold.

Biondo Investment Advisors first reported a position in LMAT in Q4 2017 and held it in 5 quarters. The position peaked at $4.24M in Q3 2018. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

  • Biondo Investment Advisors reported no remaining LeMaitre Vascular position as of Q1 2019 after selling out during the quarter.
  • Biondo Investment Advisors sold 55,605 LeMaitre Vascular shares in Q1 2019, an estimated $1.32M.
  • Biondo Investment Advisors first reported a position in LeMaitre Vascular in Q4 2017 and held it in 5 quarters.
  • Biondo Investment Advisors's LeMaitre Vascular position peaked at $4.24M in Q3 2018.
  • 155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on Biondo Investment Advisors's 13F filing for Q1 2019, filed 8 May 2019.